Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ballari Brahmachari"'
Publikováno v:
Perspectives in Clinical Research, Vol 2, Iss 2, Pp 49-53 (2011)
Keeping in mind India′s increasing participation in multinational trials, this article explores potential areas of Indian pharmacovigilance, requiring reform and provides recommendations for building a robust safety reporting system. Internal discr
Externí odkaz:
https://doaj.org/article/c2c38c799d0b42fdad8397c6fc191424
Publikováno v:
Indian Journal of Pharmacology
Although both atorvastatin and ezetimibe may cause myopathy, statin-induced myopathy is less likely at low doses, and ezetimibe is only rarely reported to induce myopathy. Also, ezetimibe is not usually known to potentiate statin-induced myopathy. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::766832a5824cc0f062e46731315687c2
http://europepmc.org/articles/PMC4621682
http://europepmc.org/articles/PMC4621682
Publikováno v:
Perspectives in Clinical Research
Perspectives in Clinical Research, Vol 2, Iss 2, Pp 49-53 (2011)
Perspectives in Clinical Research, Vol 2, Iss 2, Pp 49-53 (2011)
Keeping in mind India's increasing participation in multinational trials, this article explores potential areas of Indian pharmacovigilance, requiring reform and provides recommendations for building a robust safety reporting system. Internal discrep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd5870cd31117828511c874f220580ae
https://pubmed.ncbi.nlm.nih.gov/21731854
https://pubmed.ncbi.nlm.nih.gov/21731854
Efficacy and safety of diacerein in early knee osteoarthritis: a randomized placebo-controlled trial
Publikováno v:
Clinical rheumatology. 28(10)
The objective of this study was to evaluate the efficacy and safety of diacerein in early, symptomatic knee osteoarthritis in Indian population. Sixty-four patients of knee osteoarthritis fulfilling American College of Rheumatology Criteria were rand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98439ed0b8526350a17bf1c473e406f6
https://pubmed.ncbi.nlm.nih.gov/19597913
https://pubmed.ncbi.nlm.nih.gov/19597913
Publikováno v:
Indian Journal of Pharmacology
Objectives: Conventional polyethoxylated castor oil (PCO)-based paclitaxel is associated with major adverse drug reactions (ADRs). Nanoxel, a nanoparticle-based formulation, may improve its tolerability by removing the need for PCO vehicle, and also
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d36cc65553fadc41169af307395071e7
https://doi.org/10.4103/0253-7613.77341
https://doi.org/10.4103/0253-7613.77341